Patent ID: 8575147

Claim:
A pharmaceutical unit dosage which is a capsule shell containing a pharmaceutical composition comprising (a) 5 to 10% by weight of N-benzoyl-staurosporine; (b) 15 to 35% by weight of a hydrophilic component which is a polyethylene glycol of a molecular weight of 100 to 600 daltons, or a mixture of ethanol and the polyethylene glycol of a molecular weight of 100 to 600 daltons; (c) 30 to 55% by weight of a surfactant which is a polyoxyethylene castor oil or a mixture of a polyoxyethylene castor oil with transesterified ethoxylated vegetable oil; (d) 20 to 50% by weight of a lipophilic component which is a medium chain fatty acid triglyceride or corn oil glyceride; and (e) 0.1 to 1% by weight of an additive which is an antioxidant or an antimicrobial agent; wherein said pharmaceutical composition is suitable for oral administration and is spontaneously dispersible when diluted in an aqueous medium.